NCT02657161View on ClinicalTrials.gov

Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Rabies
Interventions
BIOLOGICAL

RABIPUR®

Biological rabies vaccine

BIOLOGICAL

PIKA rabies vaccine

Biological rabies vaccine

BIOLOGICAL

PIKA rabies vaccine with an accelerated regimen

Biological rabies vaccine

Trial Locations (1)

169608

SingHealth Investigational Medicine Unit, Singapore

All Listed Sponsors
collaborator

Duke-NUS Graduate Medical School

OTHER

lead

Yisheng Biopharma (Singapore) Pte. Ltd.

INDUSTRY

NCT02657161 - Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant | Biotech Hunter | Biotech Hunter